The Global Hub for Cost-Effective, On-Demand Radioligand Therapy
Choose Your Language:

The Global Hub for Cost-Effective, On-Demand Radioligand Therapy

Summary (10 sec read)

Radioligand therapies have revolutionized cancer treatment, offering targeted approaches for conditions like prostate and neuroendocrine tumors. However, the high costs in many countries make these treatments inaccessible to many patients. India has emerged as a global hub for cost-effective, on-demand radioligand therapies, providing world-class care at a fraction of the price found elsewhere. This article compares the costs of various radioligand therapies across different countries, highlight

Radioligand therapy (RLT) has become a game-changer in the treatment of cancers such as prostate and neuroendocrine tumors. However, the high costs of these therapies in Western countries make them inaccessible to many. India has emerged as a global hub for advanced radioligand therapies, offering world-class treatment at the lowest costs worldwide, combined with unparalleled accessibility.

This article provides a comparative overview of costs for various radioligand therapies globally and underscores why India is the preferred destination for international patients.

Global Cost Comparison of Radioligand Therapies

1. Lutetium-177 PSMA Therapy

Used primarily for prostate cancer, this targeted therapy delivers radiation directly to cancer cells.

  • United States: $30,000 to $50,000 per cycle
  • Germany: $11,000 to $16,500 per cycle
  • Turkey: $10,000 to $15,000 per cycle
  • Israel: $20,000 to $25,000 per cycle
  • United Kingdom: $19,500 to $26,000 per cycle
  • Australia: $18,000 to $21,500 per cycle
  • India: $8,530 per cycle

2. Lutetium-177 PRRT Therapy

Designed for neuroendocrine tumors, this therapy binds to specific receptors on cancer cells.

  • United States: $40,000 to $60,000 per cycle
  • Germany: $13,200 to $22,000 per cycle
  • Turkey: $12,000 to $18,000 per cycle
  • Israel: $25,000 to $30,000 per cycle
  • United Kingdom: $23,400 to $32,500 per cycle
  • Australia: $21,500 to $25,000 per cycle
  • India: $7,180 per cycle

3. Actinium-225 PSMA Therapy

An innovative treatment utilizing alpha particles, known for precision and minimal side effects.

  • United States and Europe: Still in clinical trials; costs expected to exceed other therapies
  • India: $15,000 per cycle

4. Transarterial Radioembolization (TARE) with Yttrium-90

A cutting-edge therapy for liver tumors, it delivers radiation directly to the tumor through the bloodstream.

  • United States: $50,000 to $100,000 per treatment
  • Germany: $22,000 to $44,000 per treatment
  • Turkey: $20,000 to $30,000 per treatment
  • Israel: $40,000 to $60,000 per treatment
  • United Kingdom: $32,500 to $45,500 per treatment
  • Australia: $28,500 to $35,500 per treatment
  • India: $27,865 per treatment

Additional Cost Information for Singapore, Thailand, Malaysia, and Hong Kong

While specific cost data for radioligand therapies in Singapore, Thailand, Malaysia, and Hong Kong are limited, these countries are known for their advanced medical facilities and have been offering radioligand therapies. However, the costs in these regions are generally higher compared to India. For instance, treatments in Singapore and Hong Kong can range from $20,000 to $40,000 per cycle, depending on the specific therapy and healthcare facility. Thailand and Malaysia offer more competitive pricing, but still higher than India’s rates, with costs ranging from $15,000 to $25,000 per cycle. Patients are encouraged to contact medical centers in these countries directly for the most accurate and up-to-date pricing information.

Why India is the Preferred Destination for Radioligand Therapy

Unbeatable Costs

India offers the lowest costs for radioligand therapies globally, often at a fraction of the price charged in Western countries.

On-Demand Treatment

Unlike the long waiting periods experienced in many countries, Indian centers offer quick access to treatment, with most therapies available weekly. Actinium-225 therapy, a highly specialized procedure, is performed monthly.

World-Class Expertise

India’s nuclear medicine centers are equipped with advanced technology and staffed by globally recognized experts.

Meet Dr. Ishita B. Sen: A Pioneer in Nuclear Medicine

Our center is helmed by Dr. Ishita B. Sen, a distinguished Nuclear Medicine Specialist with over two decades of experience. Dr. Sen has specialized training from leading global institutions, including Memorial Sloan Kettering Cancer Center in the USA and the University of Marburg in Germany. She is a pioneer in Nuclear Oncology and Radionuclide Therapy, with numerous publications and leadership roles in the field.

State-of-the-Art Facilities

Our center is equipped with cutting-edge technology and adheres to the highest standards of patient care. International patients are provided with comprehensive assistance, including visa facilitation, accommodation, and translation services.

Plan Your Treatment with Us

India is not just a cost-effective destination; it is a center of excellence for radioligand therapies. With experienced specialists, modern facilities, and quick access to treatment, patients can receive world-class care without financial strain.

For more information, visit www.nuclearmedicinetherapy.in.

Disclaimer

The costs mentioned are indicative and subject to change without notice. These prices have been compiled using publicly available resources. We are not responsible for any inaccuracies in the data.

By choosing India, patients can access cutting-edge radioligand therapies at the world’s lowest costs, ensuring the best of care and value.

Consult Dr Ishita B Sen

captcha

Disclaimer: This information is intended for general knowledge and informational purposes only, and does not constitute medical advice. Please consult with a qualified healthcare professional for any medical concerns or treatment decisions.

Start typing and press Enter to search